Umami Bioworks

Umami Bioworks is a Singapore-based biotechnology company that specializes in the production of cultivated seafood and marine bioactives. Founded in 2020 and formerly known as Umami Meats, the company develops an automated, modular production platform designed to be licensed to food manufacturers. By leveraging advancements in genomics, stem cell biology, and machine learning, their proprietary ALKEMYST toolkit optimizes cell growth conditions and accelerates the development of high-quality, cultivated seafood products. This approach focuses on species that are threatened, endangered, or difficult to farm, aiming to provide a sustainable alternative to traditional fishing methods.

The company's technology offers a scalable solution for the industry, enabling partners to produce cultivated fish muscle and fat in large-scale bioreactors. In addition to its core seafood programs, Umami Bioworks has expanded its platform to produce high-value marine bioactives, such as Polydeoxyribonucleotide (PDRN), for use in sectors like cosmetics and regenerative medicine. By addressing supply chain bottlenecks and providing traceability and quality controls, Umami Bioworks partners with major food suppliers to bring cultivated products to market, aiming to reduce the environmental impact of overfishing while meeting global consumer demand for sustainable protein and functional marine ingredients.